These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36546463)

  • 1. Engaging psoriasis patients in adherence and outcomes to topical treatments: A summary from the Symposium 'Tailoring topical psoriasis treatments to patients' needs and expectations' of the 30
    Bewley A; van de Kerkhof P
    J Eur Acad Dermatol Venereol; 2023 Jan; 37 Suppl 1():9-13. PubMed ID: 36546463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of topical therapies along the psoriasis patient journey: An overview from the Symposium 'Tailoring topical psoriasis treatments to patients' needs and expectations' of the 30
    Pinter A; van de Kerkhof P
    J Eur Acad Dermatol Venereol; 2023 Jan; 37 Suppl 1():3-8. PubMed ID: 36546464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel, fixed-dose calcipotriol and betamethasone dipropionate cream for the topical treatment of plaque psoriasis: Direct and indirect evidence from phase 3 trials discussed at the 30
    Pinter A; Gold LS; Reich A; Green LJ; Praestegaard M; Selmer J; Armstrong AW; Danø A; Dhawan S; Galván J; Stallknecht SE; Trebbien P; Augustin M
    J Eur Acad Dermatol Venereol; 2023 Jan; 37 Suppl 1():14-19. PubMed ID: 36546465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Real-world use, perception, satisfaction, and adherence of calcipotriol and betamethasone dipropionate PAD-cream in patients with plaque psoriasis in Spain and Germany: results from a cross-sectional, online survey.
    López Estebaranz JL; Kurzen H; Galván J
    J Dermatolog Treat; 2024 Dec; 35(1):2357618. PubMed ID: 38797809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient satisfaction and efficacy of calcipotriol plus betamethasone dipropionate gel in plaque psoriasis patients with poor adherence.
    Takahashi H; Katayama H; Uwajima Y; Koda M; Sasaki H; Tanito K; Hagiwara M; Matsuo K; Nakagawa H
    J Dermatol; 2020 Nov; 47(11):1249-1256. PubMed ID: 32734661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pooled analysis of randomized, controlled, phase 3 trials investigating the efficacy and safety of a novel, fixed dose calcipotriene and betamethasone dipropionate cream for the topical treatment of plaque psoriasis.
    Pinter A; Green LJ; Selmer J; Praestegaard M; Gold LS; Augustin M;
    J Eur Acad Dermatol Venereol; 2022 Feb; 36(2):228-236. PubMed ID: 34628687
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calcipotriol and Betamethasone Dipropionate Cream Based on PAD Technology for the Treatment of Plaque Psoriasis: A Narrative Review.
    Torres T; Galván J; Crutchley N; Praestegaard M; Iversen L; Gisondi P; Carrascosa JM; Halioua B; Bewley A; Pinter A
    Dermatol Ther (Heidelb); 2023 Oct; 13(10):2153-2169. PubMed ID: 37740858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pooled Analysis Demonstrating Superior Patient- Reported Psoriasis Treatment Outcomes for Calcipotriene/ Betamethasone Dipropionate Cream Versus Suspension/Gel.
    Armstrong A; Pinter A; Selmer J; Præstegaard M; Reich A; Koo J
    J Drugs Dermatol; 2022 Mar; 21(3):242-248. PubMed ID: 35254765
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy, Convenience, and Safety of Calcipotriene-Betamethasone Dipropionate Cream in Skin of Color Patients With Plaque Psoriasis.
    Kontzias CL; Curcio A; Gorodokin B; Tissera KA; Feldman SR; Bhatia N; Callender VD; Kircik L
    J Drugs Dermatol; 2023 Jul; 22(7):668-672. PubMed ID: 37410050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In touch with psoriasis: topical treatments and current guidelines.
    Murphy G; Reich K
    J Eur Acad Dermatol Venereol; 2011 Jun; 25 Suppl 4():3-8. PubMed ID: 21507077
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment adherence and real-life effectiveness of topical therapy in patients with mild or moderate psoriasis: uptake of scientific evidence in clinical practice and dermatologists' preferences for alternative treatment options.
    Neri L; Miracapillo A
    G Ital Dermatol Venereol; 2015 Feb; 150(1):19-26. PubMed ID: 25521808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical treatment for scalp psoriasis: Comparison of patient preference, quality of life and efficacy for non-alcoholic mometasone emulsion versus calcipotriol/betamethasone gel in daily clinical practice.
    Gual A; Pau-Charles I; Molin S
    J Dermatolog Treat; 2016; 27(3):228-34. PubMed ID: 26503824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is new in topical therapy for psoriasis?
    Reich K; Bewley A
    J Eur Acad Dermatol Venereol; 2011 Jun; 25 Suppl 4():15-20. PubMed ID: 21507079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of a fixed combination of calcipotriol/betamethasone dipropionate topical gel in adult patients with mild to moderate psoriasis: blinded interim analysis of a phase IV, multicenter, randomized, controlled, prospective study.
    Reich K; Zschocke I; Bachelez H; de Jong EM; Gisondi P; Puig L; Warren RB; Mrowietz U;
    J Eur Acad Dermatol Venereol; 2015 Jun; 29(6):1156-63. PubMed ID: 25346093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. INDIVIDUAL ARTICLE: Fixed Combination Calcipotriene/Betamethasone (Cal/BDP) Cream: Evaluating the Role of Polyaphron Dispersion (PAD) Technology in Psoriasis Treatment.
    Reddy R; Khan S; Kircik L; Armstrong AW
    J Drugs Dermatol; 2023 Aug; 22(8):SF381621s5-SF381621s10. PubMed ID: 37556526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid onset of action of calcipotriol/betamethasone dipropionate cutaneous foam in psoriasis, even in patients with more severe disease.
    Pink AE; Jalili A; Berg P; Calzavara-Pinton PG; de la Cueva Dobao P; Thaçi D; Torpet M; Jensen KL; Segaert S
    J Eur Acad Dermatol Venereol; 2019 Jun; 33(6):1116-1123. PubMed ID: 30916417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient-Reported Satisfaction With the Fixed Combination Calcipotriene/Betamethasone Dipropionate Foam for Plaque Psoriasis.
    Gorelick J; Cantrell W; Kucera K; Veverka KA; Gooding K
    J Drugs Dermatol; 2018 Aug; 17(8):880-884. PubMed ID: 30124727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to improve adherence to treatment in patients with mild-to-moderate psoriasis.
    Piaserico S; Manfredini S; Borghi A; Gisondi P; Pazzaglia M; Stinco G; Venturini M; Conti A
    G Ital Dermatol Venereol; 2018 Oct; 153(5):692-697. PubMed ID: 28704994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic review and practical guidance on the use of topical calcipotriol and topical calcipotriol with betamethasone dipropionate as long-term therapy for mild-to-moderate plaque psoriasis.
    Zhao Y; Asahina A; Asawanonda P; Frez ML; Imafuku S; Hyun Kim D; Theng C; Wang L; Zhang JA; Zimmo S
    J Dermatol; 2021 Jul; 48(7):940-960. PubMed ID: 34036631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expert recommendations: the use of the fixed combination calcipotriol and betamethasone dipropionate gel for the topical treatment of psoriasis.
    Daudén E; Bewley A; Lambert J; Girolomoni G; Cambazard F; Reich K
    J Eur Acad Dermatol Venereol; 2014 May; 28 Suppl 2():22-32. PubMed ID: 24684740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.